Oppenheimer Holdings Inc. (OPY) — Q3 2020 Form 10-Q
Reporting period: Three and nine months ended September 30, 2020. Unaudited consolidated results; amounts below are U.S. dollars. Oppenheimer operates a full-service broker-dealer and middle-market investment bank. At quarter-end, client assets under administration were $94.3 billion and assets under management were $34.5 billion.
Financial performance
| Metric | Q3 2020 | Q3 2019 | Nine months 2020 | Nine months 2019 |
|---|---|---|---|---|
| Revenue | $276.3 million | $234.8 million | $775.8 million | $737.5 million |
| Pre-tax income | $21.7 million | $6.5 million | $55.2 million | $39.9 million |
| Net income | $15.6 million | $3.9 million | $41.1 million | $27.5 million |
| Diluted EPS | $1.19 | $0.29 | $3.12 | $1.99 |
- Revenue mix and changes: Q3 revenue rose 17.7%. Investment banking revenue increased to $66.2 million from $21.8 million, while commissions grew to $92.2 million from $78.6 million. Advisory fees rose to $88.6 million from $80.9 million. Bank deposit sweep income fell to $4.6 million from $28.9 million, principally reflecting lower interest rates.
- Expenses and margins: Q3 total expenses increased 11.5% to $254.5 million; compensation rose 25.4% to $189.7 million, while non-compensation expenses declined 15.7% to $64.9 million. Private Client reported an 18.3% pre-tax margin. Capital Markets generated $19.4 million of pre-tax income versus a $6.4 million loss a year earlier.
- Cash flow: Operating activities used $148.4 million in the first nine months, versus $22.9 million provided in 2019. The filing attributes the cash-flow movements principally to changes in brokerage and customer receivables and payables. Investing activities used $3.7 million; financing activities provided $104.6 million. Cash declined $47.5 million to $32.1 million.
- Balance sheet and liquidity: Total assets were $2.61 billion and stockholders’ equity was $615.2 million at September 30, 2020. Bank call loans were $156.9 million, compared with none at year-end 2019; repurchase agreement liabilities were $252.8 million. These are broker-dealer funding balances, and cash alone is not a complete measure of the Firm’s liquidity.
Material changes and financing
- Q3 performance was led by a record investment-banking quarter, including stronger equity underwriting and advisory fees, alongside higher equities trading activity. Private Client revenue declined 7.2%, mainly due to lower interest rates, despite higher commissions and advisory fees.
- In September, the Company issued $125 million of 5.50% senior secured notes due 2025 and redeemed its 6.75% notes due 2022. Net debt carrying value was $123.9 million at quarter-end. Management said the refinancing reduced principal by about $25 million and is expected to save $3.3 million in annual interest expense; it also incurred a one-time $2.8 million charge. The Company reported compliance with note covenants.
- The Company repurchased 684,838 Class A shares for $14.2 million during the first nine months. It paid $0.36 per share in dividends during that period and announced a further $0.12 quarterly dividend after quarter-end.
Outlook, risks and contingencies
- Management’s stated strategy is to grow Private Client, Asset Management and Capital Markets through advisor and banker hiring, technology investment, selective acquisitions and disciplined expense management. No quantitative earnings or revenue guidance was provided.
- Management noted that quarter-end AUM reached a record $34.5 billion, supporting Q4 advisory fee billings. It also expects low interest rates to continue weighing on sweep income and earnings for the foreseeable future.
- COVID-19 drove widespread remote work and market volatility. The Company reported no significant business or control-process disruptions to date, but anticipated many employees would remain remote indefinitely and warned that the pandemic could adversely affect operations, revenue, liquidity and growth.
- Legal and regulatory matters include ongoing litigation, investigations and auction-rate securities obligations. For proceedings where losses were reasonably estimable, the Company disclosed a possible aggregate loss range of $0–$6.0 million above accrued amounts; some matters could not be estimated. The filing gives differing figures for remaining ARS purchase obligations: $1.3 million in the financial-statement note and $2.4 million in the legal-proceedings discussion.
- Other risks include market and interest-rate volatility, funding availability and costs, regulatory changes (including Regulation Best Interest), cybersecurity, and the possibility of losses on client or counterparty exposures. Management said disclosure controls were effective and there were no material changes in internal control over financial reporting.
Key facts for investors to verify
- Reconcile the filing’s inconsistent ARS purchase-obligation amounts ($1.3 million versus $2.4 million) and confirm the remaining scope of those commitments.
- Assess whether the Q3 investment-banking surge and elevated trading activity are sustainable, and how lower rates may continue to affect sweep income and Private Client profitability.
- Review the drivers of the $148.4 million operating cash outflow, the use and collateralization of $156.9 million in bank call loans, and the Firm’s liquidity under stressed market conditions.
- Confirm the refinancing’s realized interest savings against the stated $3.3 million annual estimate, including the effect of redemption and issuance costs.
- Monitor developments in COVID-19, legal and regulatory proceedings, cybersecurity, and the disclosed $0–$6.0 million estimated loss range, noting that actual losses may exceed the estimate.